0      0

2021 ISPE Aseptic Conference


VL21CEMAR1/SES104 - Containment - Understanding Why, When, and What Regulatory Agencies Expect


Mar 15, 2021 12:15pm ‐ Mar 15, 2021 1:15pm

Description

Containment - Understanding Why, When, and What Regulatory Agencies Expect | For10 years - the Risk Based Manufacture of Pharmaceutical Products has defined expectations for cross contamination control to protect patients. Understand what cross contamination control: why it is needed, when it is needed, how to determine the extent of what is needed, and what the regulatory environment is regarding cross contamination control to protect patients. This protection translates into requirements to also protect operators.

Session Leader(s):

Speaker(s):

  • Tom Evans, Director; Environmental Health and Safety, Abzena
  • Christoph Knoop, PhD., Principal Research Scientist, AbbVie Deutschland GmbH & Co. KG
  • Matthias Angelmaier, Global Product Manager, Isolator Technology, Syntegon Technology GmbH

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content